Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 11 of 11

Full-Text Articles in Medicine and Health Sciences

Social Motivation Is Associated With Elevated Salivary Cortisol In Boys With An Asd, Vicki Bitsika, Christopher Sharpley, Linda Agnew, Nicholas Andronicos Nov 2015

Social Motivation Is Associated With Elevated Salivary Cortisol In Boys With An Asd, Vicki Bitsika, Christopher Sharpley, Linda Agnew, Nicholas Andronicos

Vicki Bitsika

Because social communication difficulties and stress are common in children with an ASD, and because it has been hypothesised that the two are related, the association between these two variables was investigated in a sample of 90 boys with an ASD and who were aged between 6 years and 12 years of age. The Social Responsiveness Scale (SRS) was completed by the parents of these boys about their sons, plus salivary cortisol samples were collected from the boys. Results indicated that only one aspect of the boys' SRS was significantly correlated with cortisol—Social Motivation (SM). Factor analyses revealed two discrete …


Age-Related Differences In The Association Between Stereotypic Behaviour And Salivary Cortisol In Young Males With An Autism Spectrum Disorder, Vicki Bitsika, Christopher Sharpley, Linda Agnew, Nicholas Andronicos Nov 2015

Age-Related Differences In The Association Between Stereotypic Behaviour And Salivary Cortisol In Young Males With An Autism Spectrum Disorder, Vicki Bitsika, Christopher Sharpley, Linda Agnew, Nicholas Andronicos

Vicki Bitsika

To identify if age influenced the relationship between one of the central symptoms of Autism Spectrum Disorder (ASD) and physiological stress, the association between stereotypic behaviour (SB) and stress-related cortisol concentrations was examined in a sample of 150 young males with an ASD. Parent-rated SB was significantly correlated with cortisol concentrations for boys aged 6 years to 12 years but not for adolescents aged 13 years to 18 years. This age-related difference in this association was not a function of cortisol concentrations but was related to differences in SB across these two age groups. IQ did not have a significant …


Differences In The Prevalence, Severity And Symptom Profiles Of Depression In Boys And Adolescents With An Autism Spectrum Disorder Versus Normally Developing Controls, Vicki Bitsika, Christopher Sharpley Oct 2015

Differences In The Prevalence, Severity And Symptom Profiles Of Depression In Boys And Adolescents With An Autism Spectrum Disorder Versus Normally Developing Controls, Vicki Bitsika, Christopher Sharpley

Vicki Bitsika

The prevalence, severity and symptom profiles for major depressive disorder (MDD) were compared in samples of boys and adolescents with and without an autism spectrum disorder (ASD). Self-reports were obtained on the Depression subscale of the Child and Adolescent Symptoms Inventory (CASI-D) with 70 ASD and 50 non-ASD male participants between the ages of 8 and 18 from Queensland, Australia who were matched for age and IQ. Results indicated that the ASD participants had significantly higher total CASI-D scores, a greater proportion of participants who qualified for a diagnosis of MDD, and over 50% higher scores for 8 of the …


Eight-Month Test-Retest Agreement In Morning Salivary Cortisol, Self- And Parent-Rated Anxiety In Boys With An Autism Spectrum Disorder, Christopher Sharpley, Vicki Bitsika, Linda Agnew, Nicholas Andronicos Oct 2015

Eight-Month Test-Retest Agreement In Morning Salivary Cortisol, Self- And Parent-Rated Anxiety In Boys With An Autism Spectrum Disorder, Christopher Sharpley, Vicki Bitsika, Linda Agnew, Nicholas Andronicos

Vicki Bitsika

The agreement over time in morning salivary cortisol concentrations and also self- and parent-rated anxiety was investigated in a sample of 16 boys with an ASD. Cortisol and anxiety data were collected eight months apart. Results indicated that there were significant correlations between each pair of measures from the two occasions, suggesting that cortisol concentrations and anxiety did not vary much at all over that time, challenging the assumption that cortisol needs to be measured over multiple days to obtain reliable data from children with an ASD. Implications for research into the ways these children respond to chronic stressors are …


Frontal Alpha Asymmetry As A Pathway To Behavioural Withdrawal In Depression: Research Findings And Issues, Emmanuel Jesulola, Christopher Sharpley, Vicki Bitsika, Linda Agnew, Peter Wilson Oct 2015

Frontal Alpha Asymmetry As A Pathway To Behavioural Withdrawal In Depression: Research Findings And Issues, Emmanuel Jesulola, Christopher Sharpley, Vicki Bitsika, Linda Agnew, Peter Wilson

Vicki Bitsika

Depression has been described as a process of behavioural withdrawal from overwhelming aversive stressors, and which manifests itself in the diagnostic symptomatology for Major Depressive Disorder (MDD). The underlying neurobiological pathways to that behavioural withdrawal are suggested to include greater activation in the right vs the left frontal lobes, described as frontal EEG asymmetry. However, despite a previous meta-analysis that provided overall support for this EEG asymmetry hypothesis, inconsistencies and several methodological confounds exist. The current review examines the literature on this issue, identifies inconsistencies in findings and discusses several key research issues that require addressing for this field to …


Measuring Individual Burden Of Illness For Depression Among Prostate Cancer Patients, Christopher Sharpley, Vicki Bitsika, David Christie Jul 2015

Measuring Individual Burden Of Illness For Depression Among Prostate Cancer Patients, Christopher Sharpley, Vicki Bitsika, David Christie

Vicki Bitsika

Objective: This study aims to develop and test three potential models of Individual Burden of Illness for Depression (IBI-D) in prostate cancer patients. Methods: Responses to three sets of scales measuring depressive symptoms, functional impairment, and quality of life satisfaction were collected from 191 prostate cancer patients and analysed via principal components analysis to obtain weightings for each of the scales within the three sets of measures. These weightings were then used to form IBI-D Indices, and these were then compared with depressive symptoms alone for their overlap. Results: Single-factor solutions were found for each of the three IBI-D models, …


Predictors Of Depression In Prostate Cancer Patients: A Comparison Of Psychological Resilience Versus Pre-Existing Anxiety And Depression, Christopher Sharpley, Vicki Bitsika, Addie Wootten, David Christie Jul 2015

Predictors Of Depression In Prostate Cancer Patients: A Comparison Of Psychological Resilience Versus Pre-Existing Anxiety And Depression, Christopher Sharpley, Vicki Bitsika, Addie Wootten, David Christie

Vicki Bitsika

Background: Previous anxiety and depression can influence current anxiety and depression, and psychological resilience may be a buffer against current anxiety and depression. However, despite the relevance of these two sets of predictors of anxiety and depression, and their potential in treatment planning, no reports have been published on their role in post-diagnosis anxiety and depression among prostate cancer (PCa) patients. Therefore, this study aimed to determine the roles of these predictors in a sample of men with prostate cancer. Method: Retrospective self-reports of anxiety and depression for how they were before receiving their diagnosis of PCa and at the …


Four Potential Criteria For Deciding When To Use Antidepressants Or Psychotherapy For Unipolar Depression: A Literature Review, Christopher Sharpley, Vicki Bitsika Sep 2012

Four Potential Criteria For Deciding When To Use Antidepressants Or Psychotherapy For Unipolar Depression: A Literature Review, Christopher Sharpley, Vicki Bitsika

Vicki Bitsika

Objective: To evaluate the literature supporting four potential criteria for deciding whether to use psychotherapy or pharmacology when treating depression.

Method: Literature review of the evidence from the last 10 years on presenting patient’s demographics, aetiology, comorbidity, and genetic factors, as predictors of treatment outcome efficacy.

Results: Demographic information has little support as a potential criteria for decision-making; aetiology (melancholic vs. non-melancholic) has significant support; presence of personality disorder comorbidity is unproven as a criterion but may have some value; genetic predisposition has the strongest evidence supporting it as a criteria for treatment decision-making.

Conclusion: Although some presenting cases will …


How Prostate Cancer Patients Cope With The Effects Of Diagnosis And Treatment: Development Of The Effects Of Prostate Cancer Coping Strategies Scale, Christopher Sharpley, Vicki Bitsika, David Christie Sep 2012

How Prostate Cancer Patients Cope With The Effects Of Diagnosis And Treatment: Development Of The Effects Of Prostate Cancer Coping Strategies Scale, Christopher Sharpley, Vicki Bitsika, David Christie

Vicki Bitsika

Background: The elevated anxiety and depression experienced by prostate cancer (PCa) patients can impair their decision-making as well as decrease their psychological well-being and weaken relationships with partner and family. Although standardised assessment models exist for identifying the symptoms of anxiety or depression, relatively little attention has been given to identifying the causal antecedents that PCa patients encounter and that may lead to anxiety or depression, nor their own attempts to cope with those antecedents. This study investigated the coping strategies used by a sample of PCa patients in response to the specific stressors and lifestyle changes that arose from …


Variability In Anxiety And Depression Over Time Following Diagnosis In Patients With Prostate Cancer, Christoper Sharpley, David Christie, Vicki Bitsika Sep 2012

Variability In Anxiety And Depression Over Time Following Diagnosis In Patients With Prostate Cancer, Christoper Sharpley, David Christie, Vicki Bitsika

Vicki Bitsika

To determine the presence and nature of variability in anxiety and depression in patients with prostate cancer (PCa) over 3 years following diagnosis, 442 patients with PCa completed standardized anxiety and depression inventories via survey between 1 and 36 months after receiving their initial diagnosis. Data were analyzed from a series of 3-month cohorts, and results indicated that total scores and incidence of clinically significant anxiety and depression varied over time, but that this variability was restricted to specific subfactors of anxiety and depression. Provision of effective psychological treatment to patients with PCa is discussed.


Understanding The Functionality Of Depression Among Australian Breast Cancer Patients: Implications For Cognitive And Behavioural Interventions, Christopher Sharpley, Vicki Bitsika, David Christie Sep 2012

Understanding The Functionality Of Depression Among Australian Breast Cancer Patients: Implications For Cognitive And Behavioural Interventions, Christopher Sharpley, Vicki Bitsika, David Christie

Vicki Bitsika

Background: Depression in breast cancer (BCa) patients can reduce quality of life, relationships and treatment compliance, thus constituting a major target for cognitive behavioural (CBT) interventions. Although CBT treatments, which are built upon consideration of the roles of antecedents and consequences for depressive behaviour, are effective, the nature of those antecedents which trigger depression among BCa patients has received relatively little attention.

Purpose: Hypotheses were (1) to determine if BCa patients were experiencing either or both of punishment type I and II and (2) to identify if these aspects of punishment were related to overall depression.

Method: Two hundred fifty-three …